Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
This Survey is designed for laboratories utilizing APOE testing for hyperlipoproteinemia type III and Alzheimer diseases and will test for APOE e2, APOE e3, and APOE e4.
- Three 10.0‑μg extracted DNA specimens
Shipment A: March 2
Shipment B: September 14